Marlyn Expands Solid-Dose CDMO Capabilities with a Mechanistic-Integrity–Driven Manufacturing PlatformPHOENIX, May 07, 2026 (GLOBE NEWSWIRE) -- Marlyn Nutraceuticals, Inc., a specialized solid-dose Contract Development and Manufacturing Organization (CDMO), today announced the continued expansion of its integrated platform for the development, scale-up, and cGMP-compliant manufacturing of functional dietary supplements in oral solid-dosage (OSD) formats.
